20-31968641-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000562532.3(XKR7):c.466G>A(p.Glu156Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000113 in 1,587,686 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000562532.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
XKR7 | NM_001011718.2 | c.466G>A | p.Glu156Lys | missense_variant | 1/3 | ENST00000562532.3 | NP_001011718.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
XKR7 | ENST00000562532.3 | c.466G>A | p.Glu156Lys | missense_variant | 1/3 | 1 | NM_001011718.2 | ENSP00000477059.1 |
Frequencies
GnomAD3 genomes AF: 0.000118 AC: 18AN: 152164Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000151 AC: 30AN: 198224Hom.: 0 AF XY: 0.000173 AC XY: 19AN XY: 109980
GnomAD4 exome AF: 0.000112 AC: 161AN: 1435522Hom.: 0 Cov.: 31 AF XY: 0.000111 AC XY: 79AN XY: 713310
GnomAD4 genome AF: 0.000118 AC: 18AN: 152164Hom.: 0 Cov.: 32 AF XY: 0.000135 AC XY: 10AN XY: 74336
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 12, 2021 | The c.466G>A (p.E156K) alteration is located in exon 1 (coding exon 1) of the XKR7 gene. This alteration results from a G to A substitution at nucleotide position 466, causing the glutamic acid (E) at amino acid position 156 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at